General Information of the Compound
Compound ID
CP0160278
Compound Name
2,3,4-trihydroxy-5-isopropyl-N-phenyl-benzamide
    Show/Hide
Synonyms
2,3,4-trihydroxy-5-isopropyl-N-phenyl-benzamide
BDBM50196033
CHEMBL214839
    Show/Hide
Structure
Formula
C16H17NO4
Molecular Weight
287.315
Canonical SMILES
CC(C)c1cc(C(=O)Nc2ccccc2)c(O)c(O)c1O
    Show/Hide
InChI
InChI=1S/C16H17NO4/c1-9(2)11-8-12(14(19)15(20)13(11)18)16(21)17-10-6-4-3-5-7-10/h3-9,18-20H,1-2H3,(H,17,21)
    Show/Hide
InChIKey
HMVKMSUSFWLQLX-UHFFFAOYSA-N
Physicochemical Property
logP
3.1791
Rotatable Bonds
3
Heavy Atom Count
21
Polar Areas
89.79
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
4
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16090303
SID: 24736291
ChEMBL ID
CHEMBL214839
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01216, Apoptosis regulator Bcl-2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000048 PC-3 Homo sapiens (Human)  1
1
IC50 = 7000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 53100 nM
2 Ki = 24100 nM
3 Ki = 31900 nM
Clinical Information about the Compound
Drug 1 ( 2,3,4-trihydroxy-5-isopropyl-N-phenyl-benzamide )
Drug Name 2,3,4-trihydroxy-5-isopropyl-N-phenyl-benzamide
Target(s)
Apoptosis regulator Bcl-2 (BCL-2)
Inhibitor